1. Reply to K. Yokoyama et al.
- Author
-
Noel CW, Sutradhar R, Zhao H, Delibasic V, Forner D, Irish JC, Kim J, Husain Z, Mahar A, Karam I, Enepekides DJ, Chan KKW, Singh S, Hallet J, Coburn NG, and Eskander A
- Abstract
Competing Interests: John KimStock and Other Ownership Interests: Immvue Therapeutics Zain HusainResearch Funding: Merck Sharp & DohmeTravel, Accommodations, Expenses: Elekta Irene KaramHonoraria: PfizerTravel, Accommodations, Expenses: Elekta Simron SinghEmployment: Sanofi, AstraZenecaHonoraria: Novartis, IpsenResearch Funding: Novartis, EMD Serono Julie HalletHonoraria: Ipsen Antoine EskanderConsulting or Advisory Role: Bristol Myers SquibbResearch Funding: MerckNo other potential conflicts of interest were reported.
- Published
- 2021
- Full Text
- View/download PDF